179 related articles for article (PubMed ID: 23466667)
1. Inhibition of hepatitis C viral RNA-dependent RNA polymerase by α-P-boranophosphate nucleotides: exploring a potential strategy for mechanism-based HCV drug design.
Cheek MA; Sharaf ML; Dobrikov MI; Shaw BR
Antiviral Res; 2013 May; 98(2):144-52. PubMed ID: 23466667
[TBL] [Abstract][Full Text] [Related]
2. Reading, writing, and modulating genetic information with boranophosphate mimics of nucleotides, DNA, and RNA.
Shaw BR; Dobrikov M; Wang X; Wan J; He K; Lin JL; Li P; Rait V; Sergueeva ZA; Sergueev D
Ann N Y Acad Sci; 2003 Dec; 1002():12-29. PubMed ID: 14751819
[TBL] [Abstract][Full Text] [Related]
3. Efficiency of incorporation and chain termination determines the inhibition potency of 2'-modified nucleotide analogs against hepatitis C virus polymerase.
Fung A; Jin Z; Dyatkina N; Wang G; Beigelman L; Deval J
Antimicrob Agents Chemother; 2014 Jul; 58(7):3636-45. PubMed ID: 24733478
[TBL] [Abstract][Full Text] [Related]
4. 2'-deoxy-4'-azido nucleoside analogs are highly potent inhibitors of hepatitis C virus replication despite the lack of 2'-alpha-hydroxyl groups.
Klumpp K; Kalayanov G; Ma H; Le Pogam S; Leveque V; Jiang WR; Inocencio N; De Witte A; Rajyaguru S; Tai E; Chanda S; Irwin MR; Sund C; Winqist A; Maltseva T; Eriksson S; Usova E; Smith M; Alker A; Najera I; Cammack N; Martin JA; Johansson NG; Smith DB
J Biol Chem; 2008 Jan; 283(4):2167-75. PubMed ID: 18003608
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of hepatitis C virus NS5B polymerase by S-trityl-L-cysteine derivatives.
Nichols DB; Fournet G; Gurukumar KR; Basu A; Lee JC; Sakamoto N; Kozielski F; Musmuca I; Joseph B; Ragno R; Kaushik-Basu N
Eur J Med Chem; 2012 Mar; 49():191-9. PubMed ID: 22280819
[TBL] [Abstract][Full Text] [Related]
6. 2-(3-Thienyl)-5,6-dihydroxypyrimidine-4-carboxylic acids as inhibitors of HCV NS5B RdRp.
Pacini B; Avolio S; Ercolani C; Koch U; Migliaccio G; Narjes F; Pacini L; Tomei L; Harper S
Bioorg Med Chem Lett; 2009 Nov; 19(21):6245-9. PubMed ID: 19800789
[TBL] [Abstract][Full Text] [Related]
7. Current perspective of HCV NS5B inhibitors: a review.
Patil VM; Gupta SP; Samanta S; Masand N
Curr Med Chem; 2011; 18(36):5564-97. PubMed ID: 22172066
[TBL] [Abstract][Full Text] [Related]
8. [Non-hydrolysable analogs of inorganic pyrophosphate as inhibitors of hepatitis C virus RNA-dependent RNA-polymerase].
Ianvarev DV; Korovina AN; Usanov NN; Kochetkov SN
Bioorg Khim; 2012; 38(2):257-62. PubMed ID: 22792731
[TBL] [Abstract][Full Text] [Related]
9. Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymerase.
Thueng-in K; Thanongsaksrikul J; Jittavisutthikul S; Seesuay W; Chulanetra M; Sakolvaree Y; Srimanote P; Chaicumpa W
MAbs; 2014; 6(5):1327-39. PubMed ID: 25517317
[TBL] [Abstract][Full Text] [Related]
10. Non-nucleoside inhibitors of the hepatitis C virus NS5B RNA-dependant RNA polymerase: 2-aryl-3-heteroaryl-1,3-thiazolidin-4-one derivatives.
Rawal RK; Katti SB; Kaushik-Basu N; Arora P; Pan Z
Bioorg Med Chem Lett; 2008 Dec; 18(23):6110-4. PubMed ID: 18947995
[TBL] [Abstract][Full Text] [Related]
11. Novel nonnucleoside inhibitor of hepatitis C virus RNA-dependent RNA polymerase.
Howe AY; Bloom J; Baldick CJ; Benetatos CA; Cheng H; Christensen JS; Chunduru SK; Coburn GA; Feld B; Gopalsamy A; Gorczyca WP; Herrmann S; Johann S; Jiang X; Kimberland ML; Krisnamurthy G; Olson M; Orlowski M; Swanberg S; Thompson I; Thorn M; Del Vecchio A; Young DC; van Zeijl M; Ellingboe JW; Upeslacis J; Collett M; Mansour TS; O'Connell JF
Antimicrob Agents Chemother; 2004 Dec; 48(12):4813-21. PubMed ID: 15561861
[TBL] [Abstract][Full Text] [Related]
12. Nucleoside, nucleotide, and non-nucleoside inhibitors of hepatitis C virus NS5B RNA-dependent RNA-polymerase.
Sofia MJ; Chang W; Furman PA; Mosley RT; Ross BS
J Med Chem; 2012 Mar; 55(6):2481-531. PubMed ID: 22185586
[No Abstract] [Full Text] [Related]
13. Specific inhibitors of HCV polymerase identified using an NS5B with lower affinity for template/primer substrate.
McKercher G; Beaulieu PL; Lamarre D; LaPlante S; Lefebvre S; Pellerin C; Thauvette L; Kukolj G
Nucleic Acids Res; 2004; 32(2):422-31. PubMed ID: 14739234
[TBL] [Abstract][Full Text] [Related]
14. Preparation and biological evaluation of 1'-cyano-2'-C-methyl pyrimidine nucleosides as HCV NS5B polymerase inhibitors.
Mish MR; Cho A; Kirschberg T; Xu J; Zonte CS; Fenaux M; Park Y; Babusis D; Feng JY; Ray AS; Kim CU
Bioorg Med Chem Lett; 2014 Jul; 24(14):3092-5. PubMed ID: 24907145
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel inhibitors of HCV RNA-dependent RNA polymerase by pharmacophore-based virtual screening and in vitro evaluation.
Ryu K; Kim ND; Choi SI; Han CK; Yoon JH; No KT; Kim KH; Seong BL
Bioorg Med Chem; 2009 Apr; 17(8):2975-82. PubMed ID: 19332375
[TBL] [Abstract][Full Text] [Related]
16. Dual Allosteric Inhibitors Jointly Modulate Protein Structure and Dynamics in the Hepatitis C Virus Polymerase.
Brown JA; Thorpe IF
Biochemistry; 2015 Jul; 54(26):4131-41. PubMed ID: 26066778
[TBL] [Abstract][Full Text] [Related]
17. Characterization of interactions between hepatitis C virus NS5B polymerase, annexin A2 and RNA - effects on NS5B catalysis and allosteric inhibition.
Solbak SMØ; Abdurakhmanov E; Vedeler A; Danielson UH
Virol J; 2017 Dec; 14(1):236. PubMed ID: 29228983
[TBL] [Abstract][Full Text] [Related]
18. PSI-7851, a pronucleotide of beta-D-2'-deoxy-2'-fluoro-2'-C-methyluridine monophosphate, is a potent and pan-genotype inhibitor of hepatitis C virus replication.
Lam AM; Murakami E; Espiritu C; Steuer HM; Niu C; Keilman M; Bao H; Zennou V; Bourne N; Julander JG; Morrey JD; Smee DF; Frick DN; Heck JA; Wang P; Nagarathnam D; Ross BS; Sofia MJ; Otto MJ; Furman PA
Antimicrob Agents Chemother; 2010 Aug; 54(8):3187-96. PubMed ID: 20516278
[TBL] [Abstract][Full Text] [Related]
19. 5,5'- and 6,6'-dialkyl-5,6-dihydro-1H-pyridin-2-ones as potent inhibitors of HCV NS5B polymerase.
Ellis DA; Blazel JK; Tran CV; Ruebsam F; Murphy DE; Li LS; Zhao J; Zhou Y; McGuire HM; Xiang AX; Webber SE; Zhao Q; Han Q; Kissinger CR; Lardy M; Gobbi A; Showalter RE; Shah AM; Tsan M; Patel RA; LeBrun LA; Kamran R; Bartkowski DM; Nolan TG; Norris DA; Sergeeva MV; Kirkovsky L
Bioorg Med Chem Lett; 2009 Nov; 19(21):6047-52. PubMed ID: 19796938
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of hepatitis C virus RNA polymerase inhibition with dihydroxypyrimidines.
Powdrill MH; Deval J; Narjes F; De Francesco R; Götte M
Antimicrob Agents Chemother; 2010 Mar; 54(3):977-83. PubMed ID: 20028820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]